Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.

Jansen CS, Prokhnevska N, Master VA, Sanda MG, Carlisle JW, Bilen MA, Cardenas M, Wilkinson S, Lake R, Sowalsky AG, Valanparambil RM, Hudson WH, McGuire D, Melnick K, Khan AI, Kim K, Chang YM, Kim A, Filson CP, Alemozaffar M, Osunkoya AO, Mullane P, Ellis C, Akondy R, Im SJ, Kamphorst AO, Reyes A, Liu Y, Kissick H.

Nature. 2019 Dec;576(7787):465-470. doi: 10.1038/s41586-019-1836-5. Epub 2019 Dec 11.

PMID:
31827286
2.

Effects of different types of intraoral scanners and scanning ranges on the precision of digital implant impressions in edentulous maxilla: An in vitro study.

Miyoshi K, Tanaka S, Yokoyama S, Sanda M, Baba K.

Clin Oral Implants Res. 2020 Jan;31(1):74-83. doi: 10.1111/clr.13548. Epub 2019 Oct 28.

PMID:
31608509
3.

N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures.

Benicky J, Sanda M, Brnakova Kennedy Z, Goldman R.

J Biol Chem. 2019 Nov 8;294(45):16816-16830. doi: 10.1074/jbc.RA119.009989. Epub 2019 Sep 26.

PMID:
31558607
4.

Effect of Workload on Job Stress of Ghanaian OPD Nurses: The Role of Coworker Support.

Kokoroko E, Sanda MA.

Saf Health Work. 2019 Sep;10(3):341-346. doi: 10.1016/j.shaw.2019.04.002. Epub 2019 Apr 18.

5.

Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.

Takeshita S, Tanaka KA, Sawa T, Sanda M, Mizobe T, Ogawa S.

Anesth Analg. 2020 Feb;130(2):535-541. doi: 10.1213/ANE.0000000000004419.

PMID:
31490820
6.

High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores.

Morgan TM, Rossi PJ, Cutrell PK, Zhang C, Press RH, Rahnema S, Sanda M, Pattaras J, Cimmino C, Hershatter B, Jani AB, Patel PR.

Brachytherapy. 2019 Nov - Dec;18(6):793-799. doi: 10.1016/j.brachy.2019.06.001. Epub 2019 Jul 20.

PMID:
31337543
7.

Optimized Fragmentation for Quantitative Analysis of Fucosylated N-Glycoproteins by LC-MS-MRM.

Yuan W, Wei R, Goldman R, Sanda M.

Anal Chem. 2019 Jul 16;91(14):9206-9212. doi: 10.1021/acs.analchem.9b01983. Epub 2019 Jul 3.

PMID:
31268672
8.

A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients.

Connell SP, Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium, Parker C, Brewer DS, Cooper CS, Clark J.

BJU Int. 2019 May 20. doi: 10.1111/bju.14811. [Epub ahead of print]

9.

Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy.

McDonald AC, Vira M, Walter V, Shen J, Raman JD, Sanda MG, Patil D, Taioli E.

Prostate. 2019 Jun;79(9):961-968. doi: 10.1002/pros.23803. Epub 2019 Apr 8.

PMID:
30958910
10.

Single-Molecule Real-Time (SMRT) Full-Length RNA-Sequencing Reveals Novel and Distinct mRNA Isoforms in Human Bone Marrow Cell Subpopulations.

Deslattes Mays A, Schmidt M, Graham G, Tseng E, Baybayan P, Sebra R, Sanda M, Mazarati JB, Riegel A, Wellstein A.

Genes (Basel). 2019 Mar 27;10(4). pii: E253. doi: 10.3390/genes10040253.

11.

Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.

Taylor MA, Alemozaffar M, Master VA, Sanda MG, Filson CP.

Clin Genitourin Cancer. 2019 Jun;17(3):e494-e504. doi: 10.1016/j.clgc.2019.01.012. Epub 2019 Jan 26.

PMID:
30819637
12.

epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.

O'Reilly E, Tuzova AV, Walsh AL, Russell NM, O'Brien O, Kelly S, Dhomhnallain ON, DeBarra L, Dale CM, Brugman R, Clarke G, Schmidt O, O'Meachair S, Patil D, Pellegrini KL, Fleshner N, Garcia J, Zhao F, Finn S, Mills R, Hanna MY, Hurst R, McEvoy E, Gallagher WM, Manecksha RP, Cooper CS, Brewer DS, Bapat B, Sanda MG, Clark J, Perry AS.

JCO Precis Oncol. 2019;2019. doi: 10.1200/PO.18.00134. Epub 2019 Jan 14.

13.

Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.

Einstein DJ, Patil D, Chipman J, Regan MM, Davis K, Crociani CM, Wagner AA, Sanda MG, Chang P.

Urology. 2019 May;127:53-60. doi: 10.1016/j.urology.2019.02.004. Epub 2019 Feb 18.

PMID:
30790648
14.

Comparison of immediate and conventional loading protocols with respect to marginal bone loss around implants supporting mandibular overdentures: A systematic review and meta-analysis.

Sanda M, Fueki K, Bari PR, Baba K.

Jpn Dent Sci Rev. 2019 Nov;55(1):20-25. doi: 10.1016/j.jdsr.2018.09.005. Epub 2018 Oct 24. Review.

15.

Brachytherapy for localized prostate cancer in the modern era: a comparison of patient-reported quality of life outcomes among different techniques.

Morgan TM, Press RH, Cutrell PK, Zhang C, Chen Z, Rahnema S, Sanda M, Pattaras J, Patel PR, Jani AB, Rossi PJ.

J Contemp Brachytherapy. 2018 Dec;10(6):495-502. doi: 10.5114/jcb.2018.81024. Epub 2018 Dec 28.

16.

Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.

Wilson LS, Blonquist TM, Hong F, Halpenny B, Wolpin S, Chang P, Filson CP, Master VA, Sanda MG, Chien GW, Jones RA, Krupski TL, Berry DL.

BMC Med Inform Decis Mak. 2019 Jan 9;19(1):6. doi: 10.1186/s12911-018-0725-4.

17.

Chemoenzymatic synthesis of glycopeptides bearing rare N-glycan sequences with or without bisecting GlcNAc.

Yang W, Ramadan S, Orwenyo J, Kakeshpour T, Diaz T, Eken Y, Sanda M, Jackson JE, Wilson AK, Huang X.

Chem Sci. 2018 Aug 31;9(43):8194-8206. doi: 10.1039/c8sc02457j. eCollection 2018 Nov 21.

18.

Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns.

Liu W, Patil D, Howard DH, Moore RH, Wang H, Sanda MG, Filson CP.

Urol Oncol. 2019 Mar;37(3):181.e15-181.e21. doi: 10.1016/j.urolonc.2018.11.004. Epub 2018 Dec 1.

PMID:
30514604
19.

Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer.

Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ.

Clin Genitourin Cancer. 2019 Feb;17(1):32-37. doi: 10.1016/j.clgc.2018.09.022. Epub 2018 Oct 4.

PMID:
30348512
20.

Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands.

Press RH, Morgan TM, Cutrell PK, Zhang C, Chen Z, Rahnema S, Sanda M, Pattaras J, Patel P, Jani AB, Rossi PJ.

Brachytherapy. 2019 Jan - Feb;18(1):13-21. doi: 10.1016/j.brachy.2018.08.009. Epub 2018 Sep 25.

PMID:
30262410
21.

Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: patient reported quality of life outcomes.

Morgan TM, Press RH, Cutrell PK, Zhang C, Chen Z, Rahnema S, Jhaveri J, Sanda M, Pattaras J, Patel P, Jani AB, Rossi PJ.

J Contemp Brachytherapy. 2018 Jun;10(3):211-217. doi: 10.5114/jcb.2018.76980. Epub 2018 Jun 30.

22.

Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.

Yuan W, Benicky J, Wei R, Goldman R, Sanda M.

J Proteome Res. 2018 Aug 3;17(8):2755-2766. doi: 10.1021/acs.jproteome.8b00201. Epub 2018 Jul 16.

23.

Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP.

Mihalcik SA, Chipman JJ, Sanda MG, Regan MM, Kaplan ID, Wagner AA, Crociani CM, Chang P; PROST-QA Consortium.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):445-451. doi: 10.1016/j.prro.2018.04.007. Epub 2018 Apr 14. No abstract available.

PMID:
29935957
24.

Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers.

Kozlik P, Goldman R, Sanda M.

Anal Bioanal Chem. 2018 Aug;410(20):5001-5008. doi: 10.1007/s00216-018-1150-3. Epub 2018 May 28.

25.

Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.

Liu W, Patil D, Howard DH, Moore RH, Wang H, Sanda MG, Filson CP.

Urology. 2018 Jul;117:57-63. doi: 10.1016/j.urology.2018.04.007. Epub 2018 Apr 18.

PMID:
29679601
26.

Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis.

Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M.

Cancer Treat Rev. 2018 May;66:23-44. doi: 10.1016/j.ctrv.2018.03.005. Epub 2018 Apr 3. Review.

PMID:
29673922
27.

Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.

Ma J, Sanda M, Wei R, Zhang L, Goldman R.

J Proteomics. 2018 Oct 30;189:67-74. doi: 10.1016/j.jprot.2018.02.003. Epub 2018 Feb 7.

28.

Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.

Ankerst DP, Goros M, Tomlins SA, Patil D, Feng Z, Wei JT, Sanda MG, Gelfond J, Thompson IM, Leach RJ, Liss MA.

Eur Urol Focus. 2019 Jan;5(1):54-61. doi: 10.1016/j.euf.2018.01.010. Epub 2018 Feb 13.

29.

Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer.

McDonald AC, Vira M, Shen J, Sanda M, Raman JD, Liao J, Patil D, Taioli E.

Prostate. 2018 May;78(6):411-418. doi: 10.1002/pros.23485. Epub 2018 Jan 31.

PMID:
29383739
30.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.

J Urol. 2018 Apr;199(4):990-997. doi: 10.1016/j.juro.2018.01.002. Epub 2018 Jan 10.

PMID:
29331546
31.

In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.

Elfatairy KK, Filson CP, Sanda MG, Osunkoya AO, Geller RL, Nour SG.

Br J Radiol. 2018 Apr;91(1084):20170603. doi: 10.1259/bjr.20170603. Epub 2018 Feb 13.

32.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.

J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15. Review.

PMID:
29203269
33.

Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Pro.

Sanda MG.

J Urol. 2017 Nov;198(5):997-999. doi: 10.1016/j.juro.2017.08.089. Epub 2017 Sep 22. Review. No abstract available.

PMID:
28947083
34.

Nano reversed phase versus nano hydrophilic interaction liquid chromatography on a chip in the analysis of hemopexin glycopeptides.

Kozlik P, Sanda M, Goldman R.

J Chromatogr A. 2017 Oct 13;1519:152-155. doi: 10.1016/j.chroma.2017.08.066. Epub 2017 Aug 26.

35.

Influence of Bisphosphonates on Implant Failure Rates and Characteristics of Postmenopausal Woman Mandibular Jawbone.

Yajima N, Munakata M, Fuchigami K, Sanda M, Kasugai S.

J Oral Implantol. 2017 Oct;43(5):345-349. doi: 10.1563/aaid-joi-D-17-00015. Epub 2017 Sep 5.

PMID:
28873023
36.

Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.

Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M, Somayaji P.

J Urol. 2018 Jan;199(1):89-97. doi: 10.1016/j.juro.2017.07.076. Epub 2017 Jul 25.

37.

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM Jr, Siddiqui J, Fan J, Joon AY, Bantis LE, Rubin MA, Chinnayian AM, Wei JT; and the EDRN-PCA3 Study Group, Bidair M, Kibel A, Lin DW, Lotan Y, Partin A, Taneja S.

JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.

38.

Acid rain footprint three decades after peak deposition: Long-term recovery from pollutant sulphate in the Uhlirska catchment (Czech Republic).

Marx A, Hintze S, Sanda M, Jankovec J, Oulehle F, Dusek J, Vitvar T, Vogel T, van Geldern R, Barth JAC.

Sci Total Environ. 2017 Nov 15;598:1037-1049. doi: 10.1016/j.scitotenv.2017.04.109. Epub 2017 May 1.

PMID:
28476077
39.

External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.

Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P; Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium, Michalski JM.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):304-317. doi: 10.1016/j.ijrobp.2017.02.019. Epub 2017 Feb 22.

40.

Study of structure-dependent chromatographic behavior of glycopeptides using reversed phase nanoLC.

Kozlik P, Goldman R, Sanda M.

Electrophoresis. 2017 Sep;38(17):2193-2199. doi: 10.1002/elps.201600547. Epub 2017 May 17.

41.

Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.

Pellegrini KL, Patil D, Douglas KJS, Lee G, Wehrmeyer K, Torlak M, Clark J, Cooper CS, Moreno CS, Sanda MG.

Prostate. 2017 Jun;77(9):990-999. doi: 10.1002/pros.23355. Epub 2017 Apr 17.

42.

Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.

Wang M, Sanda M, Comunale MA, Herrera H, Swindell C, Kono Y, Singal AG, Marrero J, Block T, Goldman R, Mehta A.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):795-803. doi: 10.1158/1055-9965.EPI-16-0974. Epub 2017 Feb 21.

43.

Impact of land use on water quality in the upper Nisa catchment in the Czech Republic and in Germany.

Kändler M, Blechinger K, Seidler C, Pavlů V, Šanda M, Dostál T, Krása J, Vitvar T, Štich M.

Sci Total Environ. 2017 May 15;586:1316-1325. doi: 10.1016/j.scitotenv.2016.10.221. Epub 2017 Feb 12. No abstract available.

PMID:
28202236
44.

Neoadjuvant Enzalutamide Prior to Prostatectomy.

Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin DW, Sanda M, Novotny W, Wu K, Kantoff PW, Marck BT, Plymate S, Balk SP, Nelson PS, Matsumoto AM, Lis RT, Kibel A, Haas GP, Krivoshik A, Hannah A, Taplin ME.

Clin Cancer Res. 2017 May 1;23(9):2169-2176. doi: 10.1158/1078-0432.CCR-16-1357. Epub 2016 Nov 9.

45.

Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4.

Sowalsky AG, Kissick HT, Gerrin SJ, Schaefer RJ, Xia Z, Russo JW, Arredouani MS, Bubley GJ, Sanda MG, Li W, Ye H, Balk SP.

Clin Cancer Res. 2017 Jul 15;23(14):3823-3833. doi: 10.1158/1078-0432.CCR-16-2414. Epub 2017 Jan 24.

46.

Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.

O'Malley PG, Nguyen DP, Al Hussein Al Awamlh B, Wu G, Thompson IM, Sanda M, Rubin M, Wei JT, Lee R, Christos P, Barbieri C, Scherr DS.

J Urol. 2017 Jul;198(1):42-49. doi: 10.1016/j.juro.2017.01.058. Epub 2017 Jan 20.

47.

Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.

Pellegrini KL, Sanda MG, Patil D, Long Q, Santiago-Jiménez M, Takhar M, Erho N, Yousefi K, Davicioni E, Klein EA, Jenkins RB, Karnes RJ, Moreno CS.

BJU Int. 2017 Jun;119(6):961-967. doi: 10.1111/bju.13779. Epub 2017 Feb 11.

48.

Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.

Sanda M, Zhang L, Edwards NJ, Goldman R.

Anal Bioanal Chem. 2017 Jan;409(2):619-627. doi: 10.1007/s00216-016-0041-8. Epub 2016 Nov 7.

49.

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):770-777. doi: 10.1016/j.ijrobp.2016.07.038. Epub 2016 Aug 3.

PMID:
27663760
50.

Data Independent Analysis of IgG Glycoforms in Samples of Unfractionated Human Plasma.

Sanda M, Goldman R.

Anal Chem. 2016 Oct 18;88(20):10118-10125. Epub 2016 Sep 29.

Supplemental Content

Support Center